Skip to content
★ Sign in to follow
PH

Philippe H. Marco

Xtent Inc
Total declarations
159
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (159 ops.)
€283k

Latest filing published 01 Oct 2008 for XTENT INC, €267.

Insider track record

Disclosed buys
0
Disclosed sells
159
Signal history

No signal scores available.

Philippe H. Marco: trading record in brief

Philippe H. Marco appears in our data through filings on Xtent Inc shares, published by SEC (Form 4). Between 4 September 2007 and 1 October 2008, the trades on record add up to 159 filings.

The open-market record consists of 159 sales worth €283k, with no purchase. Since January 2008: no purchases and 94 sales on the market.

The newest entry dates from 1 October 2008: an open-market sale of €507, in Xtent Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Philippe H. Marco

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations153 total
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    369 USD0SEC
    300 shares@ US$1.23Common StockSEC:0001212235-08-000113:0
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    125 USD0SEC
    100 shares@ US$1.25Common StockSEC:0001212235-08-000113:1
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    1,040 USD0SEC
    800 shares@ US$1.30Common StockSEC:0001212235-08-000113:2
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    131 USD0SEC
    100 shares@ US$1.31Common StockSEC:0001212235-08-000113:3
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    396 USD0SEC
    300 shares@ US$1.32Common StockSEC:0001212235-08-000113:4
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    266 USD0SEC
    200 shares@ US$1.33Common StockSEC:0001212235-08-000113:5
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    670 USD0SEC
    500 shares@ US$1.34Common StockSEC:0001212235-08-000113:6
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    1,890 USD0SEC
    1,400 shares@ US$1.35Common StockSEC:0001212235-08-000113:7
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    136 USD0SEC
    100 shares@ US$1.36Common StockSEC:0001212235-08-000113:8
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    414 USD0SEC
    300 shares@ US$1.38Common StockSEC:0001212235-08-000113:9
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    417 USD0SEC
    300 shares@ US$1.39Common StockSEC:0001212235-08-000113:10
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    700 USD0SEC
    500 shares@ US$1.40Common StockSEC:0001212235-08-000113:11
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    141 USD0SEC
    100 shares@ US$1.41Common StockSEC:0001212235-08-000113:12
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    99 USD0SEC
    50 shares@ US$1.97Common StockSEC:0001212235-08-000112:0
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    8,800 USD0SEC
    4,400 shares@ US$2.00Common StockSEC:0001212235-08-000112:1
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    704 USD0SEC
    350 shares@ US$2.01Common StockSEC:0001212235-08-000112:2
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    205 USD0SEC
    100 shares@ US$2.05Common StockSEC:0001212235-08-000112:3
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    207 USD0SEC
    100 shares@ US$2.07Common StockSEC:0001212235-08-000112:4
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    253 USD0SEC
    100 shares@ US$2.53Common StockSEC:0001212235-08-000098:0
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    5,610 USD0SEC
    2,200 shares@ US$2.55Common StockSEC:0001212235-08-000098:1
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    256 USD0SEC
    100 shares@ US$2.56Common StockSEC:0001212235-08-000098:2
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    257 USD0SEC
    100 shares@ US$2.57Common StockSEC:0001212235-08-000098:3
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    2,600 USD0SEC
    1,000 shares@ US$2.60Common StockSEC:0001212235-08-000098:4
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    8,505 USD0SEC
    3,500 shares@ US$2.43Common StockSEC:0001212235-08-000094:0
  • ▼
    VP-QA, Clinical & Reg. AffairsExecutivesXtent Inc
    1,360 USD0SEC
    400 shares@ US$3.40Common StockSEC:0001212235-08-000062:0

25 of 153 declarations